Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | XDH | P47989 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14422820 | 0.89 | KLF10 (0.49) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL3706546 | 0.86 | GABRA1 (0.59) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL25689805 | 0.82 | ESR1 (0.53) | ALDH1A1GABRA1GABRB2CYP2D6PTPN1 | |
| SCHEMBL1986356 | 0.82 | GABRA1 (0.46) | ALDH1A1HPGDGABRA1GABRB2MAPT | |
| SCHEMBL10233336 | 0.79 | ALDH1A1 (0.57) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL51349 | 0.79 | ALDH1A1 (0.61) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| Hydrochloric Acid SCHEMBL250215 | 0.78 | ALDH1A1 (0.55) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL25689814 | 0.78 | CYP1A2 (0.39) | ALDH1A1HPGDHSD17B10GABRA1GABRB2 | |
| SCHEMBL11480932 | 0.77 | GABRA1 (0.41) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL4508763 | 0.77 | ALDH1A1 (0.59) | ALDH1A1HPGDALOX15HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2334624-B1 | PROCESS FOR MAKING 2-SECONDARY-ALKYL-4,5-DI-(NORMAL-ALKYL)PHENOLS | INVISTA TECHNOLOGIES SRL (CH) | 2014-10-01 | — | — | EP | disclosed |
| US-8247621-B2 | Process for making 2-secondary-alkyl-4,5-di-(normal-alkyl)phenols | INVISTA NORTH AMERICA S.A.R.L. (US) | 2012-08-21 | — | — | US | disclosed |
| EP-2334624-A1 | PROCESS FOR MAKING 2-SECONDARY-ALKYL-4,5-DI-(NORMAL-ALKYL)PHENOLS | Invista Technologies S.A R.L. (CH) | 2011-06-22 | — | — | EP | disclosed |
| WO-2010045131-A1 | PROCESS FOR MAKING 2-SECONDARY-ALKYL-4,5-DI-(NORMAL-ALKYL)PHENOLS | INVISTA TECHNOLOGIES S.A.R.L. (CH) | 2010-04-22 | — | — | WO | disclosed |
| US-20100099922-A1 | PROCESS FOR MAKING 2-SECONDARY-ALKYL-4,5-DI-(NORMAL-ALKYL)PHENOLS | INVISTA NORTH AMERICA S.A.R.L. (US) | 2010-04-22 | — | — | US | disclosed |
| EP-0445827-B1 | 4-Hydroxytetrahydropyran-2-one derivatives useful as cholesterol and lipid reducing agents | FUJIREBIO KK (JP) | 1996-09-25 | — | — | EP | disclosed |
| US-5149834-A | Anticholesterol agent and enzyme inhibitors, for curing arteriosclerosis | FUJIREBIO INC. (JP) | 1992-09-22 | — | — | US | disclosed |
| EP-0445827-A2 | 4-Hydroxytetrahydropyran-2-one derivatives useful as cholesterol and lipid reducing agents | FUJIREBIO INC. (JP) | 1991-09-11 | — | — | EP | disclosed |
| US-4236031-A | FROM 3-ALKYLPHENOLS OR 2,3-DIALKYLPHENOLS | CONOCO, INC. (US) | 1980-11-25 | — | — | US | disclosed |
| US-4236031-A | FROM 3-ALKYLPHENOLS OR 2,3-DIALKYLPHENOLS | CONOCO, INC. (US) | 1980-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100099922-A1 | PROCESS FOR MAKING 2-SECONDARY-ALKYL-4,5-DI-(NORMAL-ALKYL)PHENOLS | UGT1A4, CYP4B1, CYP4X1 | ALDH1A1 513/4885HPGD 1803/4885ALOX15 387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.